http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009520838-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-728 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-16 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728 |
filingDate | 2006-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2009-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2009520838-A |
titleOfInvention | Bismuth hyaluronate, its preparation and use |
abstract | The present invention discloses bismuth hyaluronate, characterized in that the bismuth content is 0.5% to 40% and the glucuronate content is 20% to 45% based on the dry weight. Similarly provided is a reaction of the soluble bismuth hyaluronate with the reaction of soluble hyaluronate and bismuth salt in a basic aqueous solution followed by precipitation, filtration, desalting, dehydration and drying. It is a preparation method. Further disclosed is the use of bismuth hyaluronate in the manufacture of a medicament or health food for the prevention and treatment of gastrointestinal disorders, in particular GI ulcer disorders. It has been demonstrated in animal experiments that it has a better therapeutic effect compared to the same type of product. [Selection figure] None |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018524558-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018517132-A |
priorityDate | 2005-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 95.